Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

OMER:US

21.4200 USD 0.6500 3.13%

As of 12:40:22 ET on 05/06/2015.

Company Profile for Omeros Corp (OMER)

Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.

Contact Information

Omeros Corp

1420 Fifth Avenue
Suite 2600
Seattle, WA 98101
United States
Phone: 1-206-676-5000
Fax: 1-206-676-5005

Key Executives for Omeros Corp (OMER)

Gregory A DemopulosChairman/Pres/CEO/Co-FounderMichael A JacobsenVP:Finance/Chief Acctg Officer
George A GaitanarisVP:Science/Chief Scientific OfcrJ Steven WhitakerVP:Clinical/Chief Medical Ofcr
Kenneth M FergusonVP:Dev/Chief Dev OfcrMarcia S KelbonVP:Patent/Secy/General Counsel
Catherine A Melfi "Cathy"VP:Regulatory AffairsTimothy M DuffyVP:Business Development
William J LambertVP:Chemistry & ManufacturingPatricia SandlerVP:Sales & Marketing

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil